Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia

AIDS Research and Human Retroviruses

Volumn 20, Issue 11, 2004, Pages 1148-1156

  Zetterberg, Veera ^a   Ustina, Valentina ^b   Liitsola, Kirsi ^a   Zilmer, Kai ^b   Kalikova, Nelli ^c   Sevastianova, Ksenia ^a   Brummer Korvenkontio, Henrikki ^a   Leinikki, Pauli ^a   Salminen, Mika O ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Merimetsa Hospital   (Estonia)

^c AIDS Prevention Center   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; EPIDEMIC; ESTONIA; EUROPE; FEMALE; GENE SEQUENCE; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNINDEXED SEQUENCE; VIRUS GENE; VIRUS STRAIN;

DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; ESTONIA; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 9344246865     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1148     Document Type: Article

References (57)

1. Uuskula A, Kalikova A, Zilmer K, Tammai L, and DeHovitz J: The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia. Int J Infect Dis 2002;6:23-27.
2. Hamers FF, Infuso A, Alix J, and Downs AM: Current situation and regional perspective on HIV/AIDS surveillance in Europe. J Acquir Immune Defic Syndr 2003;32(Suppl. 1):S39-48.
3. Lukashov VV, Cornelissen MT, Goudsmit J, et al.: Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania. AIDS 1995;9:435-439.
4. Axmann A: Eastern Europe and Community of Independent States. Int Migr 1998;36:587-607.
5. Number of HIV carriers up in Kazakstan. AIDS Wkly Plus 1996:14-15.
6. Dehne KL, Khodakevich L, Hamers FF, and Schwartlander B: The HIV/AIDS epidemic in eastern Europe: Recent patterns and trends and their implications for policy-making. AIDS 1999;13:741-749.
7. Kelly JA and Amirkhanian YA: The newest epidemic: A review of HIV/AIDS in Central and Eastern Europe. Int J STD AIDS 2003;14:361-371.
8. Liitsola K, Tashkinova I, Laukkanen T, et al.: HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-1919.
9. Liitsola K, Holm K, Bobkov A, et al.: An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res Hum Retroviruses 2000;16:1047-1053.
10. Mashkilleyson N and Leinikki P: Evolution of the HIV epidemic in Kaliningrad, Russia. J Clin Virol 1999;12:37-42.
11. Liitsola K, Laukkanen T, Denisova A, et al.: Genetic characterization of HIV-1 strains in the Baltic countries and Russia. Scand J Infect Dis 1996;28:537-541.
12. Ferdats A, Konicheva V, Dievberna I, Lilja E, and Albert J: An HIV type 1 subtype A outbreak among injecting drug users in Latvia. AIDS Res Hum Retroviruses 1999;15:1487-1490.
13. Liitsola K, Ristola M, Holmstrom P, et al.: An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS 2000;14:2613-2615.
14. Liitsola K, Holmstrom P, Laukkanen T, et al.: Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data. Scand J Infect Dis 2000;32:475-480.
15. Thomson MM, Delgado E, Manjon N, et al.: HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 2001;15:509-516.
16. Ustina V, Zilmer K, Tammai L, et al.: Epidemiology of HIV in Estonia. AIDS Res Hum Retroviruses 2001;17:81-85.
17. Salminen M, Nykanen A, Brummer-Korvenkontio H, et al.: Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993;195:185-194.
18. Smith SW, Overbeek R, Woese CR, Gilbert W, and Gillevet PM: The Genetic Data Environment: an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994;10:671-675.
19. Higgins DAU: Clustal: A package for performing multiple sequence alignment on a microcomputer. Gene 1990;73:237-244.
20. Higgins D, Bleasby A, and Fuchs R: Clustal V: Improved software for multiple sequence alignment. Cabios 1992;8:189-191.
21. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
22. Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985;39:783-791.
23. Salminen MO, Carr JK, Burke DS, and McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning, AIDS Res Hum Retroviruses 1995;11:1423-1425.
24. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
25. Felsenstein J: PHYLIP: Phylogeny inference package, v.3.572c. Seattle, WA: University of Washington, 1996.
26. Felsenstein J: Phylogenies from molecular sequences: Inference and reliability. Ann Rev Genet 1988;22:521-565.
27. Bobkov A, Kazennova E, Khanina T, et al.: An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: Study of the new local outbreaks in Moscow and Irkutsk. AIDS Res Hum Retroviruses 2001;17: 257-261.
28. Bobkova MR, Kazennova EV, Selimova LM, et al.: Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: Evidence of subtype homogeneity at the main sites of the epidemic. Int J STD AIDS 2001;12:34-40.
29. Oelrichs RB, Workman C, Laukkanen T, McCutchan FE, and Deacon NJ: A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res Hum Retroviruses 1998; 14:1495-1500.
30. Montavon C, Bibollet-Ruche F, Robertson D, et al.: The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. AIDS Res Hum Retroviruses 1999;15: 1707-1712.
31. Triques K, Bourgeois A, Vidal N, et al.: Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses 2000;16:139-151.
32. Montavon C, Toure-Kane C, Nkengasong JN, et al.: CRF06-cpx: A new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr 2002;29:522-530.
33. Ouedraogo-Traore R, Montavon C, Sanou T, et al.: CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso. AIDS 2003;17:441-442.
34. Mamadou S, Vidal N, Montavon C, et al.: Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. AIDS Res Hum Retroviruses 2003; 19:77-82.
35. Baldrich-Rubio E, Anagonou S, Stirrups K, et al.: A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. J Gen Virol 2001;82:1095-1106.
36. Lukashov VV and Goudsmit J: Recent evolutionary history of human immunodeficiency virus type 1 subtype B: Reconstruction of epidemic onset based on sequence distances to the common ancestor. J Mol Evol 2002;54:680-691.
37. Leitner T, Kumar S, and Albert J: Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J Virol 1997;71:4761-4770.
38. Shankarappa R, Margolick JB, Gange SJ, et al.: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999;73:10489-10502.
39. Bobkov A, Cheingsong-Popov R, Selimova L, et al.: An HIV-1 epidemic among injecting drug users in the former Soviet Union caused by a homogenous subtype A strain. AIDS Res Hum Retroviruses 1997;13:1195-1201.
40. Khodakevich L: Development of HIV epidemics in Belarus, Moldova and Ukraine and response to the epidemics. Eighth International Conference on the Reduction of Drug Related Harm, Paris, 1997.
41. Kobyshka Y, Shcerbinskaya A, Khodakevich L, Andrushchak L, Kruglow Y: HIV infection among drug users in Ukraine: Beginning of the epidemic. XI International Conference on AIDS, Vancouver, 1996 (Abstract TuC204).
42. Bertrand P: [AIDS in Russia. It is still possible to stop the epidemic. Interview with Dr. A.P. Koslov]. SidAlerte 1996:9-10.
43. HIV spreading among women and children in Asia and Eastern Europe. AIDS Wkly Plus 1996:17-18.
44. Novitsky VA, Montano MA, and Essex M: Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses 1998;14: 1079-1085.
45. Epidemiology of HIV/AIDS in the North-West Region of the Russian Federation. Epidemiological Bulletin of the St. Petersburg Pasteur Institute. North-West District AIDS Centre of the Russian Federation Ministry of Public Health: St. Petersburg Pasteur Institute, 2002.
46. Liitsola K, Holm K, Bobkov A, et al.: An A/B recombinant HIV-1 and its parental strains circulating in Russia: Low requirements for sequence identity in recombination. AIDS Res Hum Retroviruses 2000;16:1047-1053.
47. Liitsola K, Laukkanen T, Denisova A, et al.: Genetic characterization of HIV-1 strains in the Baltic countries and Russia. Scand J Infect Dis 1996;28:537-541.
48. Huang Y, Paxton WA, Wolinsky SM, et al.: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-1243.
49. Bratt G, Sandstrom E, Albert J, Samson M, and Wahren B: The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene. AIDS 1997;11:1415-1419.
50. Berson JF, Long D, Doranz BJ, et al.: A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996;70:6288-6295.
51. Balter M: A second coreceptor for HIV in early stages of infection. Science 1996;272:1740.
52. Simmons G, Wilkinson D, Reeves JD, et al.: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-8360.
53. Hamers FF, Downs AM, Infuso A, and Brunet JB: Diversity of the HIV/AIDS epidemic in Europe. AIDS 1998;12(Suppl A):S63-70.
54. Hamers FF, Batter V, Downs AM, et al.: The HIV epidemic associated with injecting drug use in Europe: Geographic and time trends. AIDS 1997;11:1365-1374.
55. Hsieh YH and Cooke K: Behaviour change and treatment of core groups: Its effect on the spread of HIV/AIDS. IMA J Math Appl Med Biol 2000;17:213-241.
56. Grassly NC, Garnett GP, Schwartlander B, Gregson S, and Anderson RM: The effectiveness of HIV prevention and the epidemiological context, Bull WHO 2001;79:1121-1132.
57. Pisani E, Garnett GP, Grassly NC, et al.: Back to basics in HIV prevention: Focus on exposure. Br Med J 2003;326:1384-1387.